Applied StemCell
Milpitas, US · Delaware corporation · 1 known investors
Leading CRO/CDMO specializing in cell and gene therapy with proprietary TARGATT genome editing and iPSC platform
Founders & leadership
RJ
Ruhong JiangExecutive Officer, Director
ZX
Zhenyu XiaoDirector
GY
Guoliang YuDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$19MraisedOct 2016 · 6 investors · BiotechnologyRule 506(b)
▶$19MraisedOct 2016 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ruhong JiangExecutive Officer, Director
- Zhenyu XiaoDirector
- Guoliang YuDirector
- Offering amount
- $19M
- Amount sold
- $19M
- Minimum investment
- $1
- First sale
- May 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.